fda warning letter hims & hers compounded semaglutide september 2025 issued 25 letters to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Issues Warnings Against Illegal

Under the if-all-adhere estimand, CagriSema produced 23.0% weight loss at 84 weeks, against 25.5% for tirzepatide

Your geographic location, state of residence, and insurance status also shape treatment affordability

So much for the easy fix heres what often comes with it: Physical setbacks like nausea, bloating, fatigue, and digestive discomfort quietly test the bodys tolerance

The supernatant was removed and cell pellets were immediately lysed and RNA was extracted using a Qiashredder extraction column (Cat

The effects of GLP-1 infusion have also been studied on animal models of arrhythmias

I also realized that it's okay to look for answers outside of the standard health system